¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"chromosome fragile sites"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® sex chromosome ÇÑ±Û ¼º¿°»öü
¼³¸í   
  ¾Ï¼öÀÇ ¼ºÀ» °áÁ¤Çϴ µ¥ Áß¿äÇÑ ±¸½ÇÀ» Çϴ ¿°»öü. À̰Ϳ¡ ´ëÇÏ¿© º¸ÅëÀÇ ¿°»öü¸¦ º¸Åë¿°»öü¶ó°í ÇÑ´Ù. ¾Ï¼öÀÇ ±¸º°ÀÌ Àִ »ý¹°¿¡¼­´Â ¾Ï¼ö¿¡ µû¶ó ´Ù¸¥ Çü°ú ¼ö¸¦ ³ªÅ¸³»´Â ¿°»öüÀ̸ç, º¸Åë¿°»öü¿¡ ºñÇØ ¿°»ö¼ºÀ̳ª Çൿ¿¡¼­ Â÷À̰¡ ÀÖ´Ù. Æ¯È÷ µ¿¹°ÀÇ ¼º¿°»öü´Â ±×·± °æÇâÀÌ °­ÇÏ´Ù. ÈÞÁö±â ¹× Çٺп­ Àü±â¿¡ ¶Ñ·ÇÇÑ ÀÌ»óÀÀÃàÀ» ³ªÅ¸³»¸ç °¨¼öºÐ¿­ ¶§´Â ´Ù¸¥ ¿°»öüº¸´Ù ¸ÕÀú ¾Õ¼­°Å³ª ²ø·Á°¡´Â ÇൿÀ» º¸¿©ÁØ´Ù. 
¿µ¹® chromosome ÇÑ±Û ¿°»öü
¼³¸í   
  À¯ÀüÁ¤º¸¸¦ ´ã°í Àִ DNA°¡ ¸ð¿©¼­ ÀÌ·ç´Â ±¸Á¶¹°·Î ÇÙ¼Ó¿¡ À§Ä¡ÇÑ´Ù. ¼¼Æ÷°¡ ºÐ¿­ÇÒ ¶§ À̰ÍÀ» ´õ¿í ¶Ñ·ÇÀÌ °üÂûÇÒ ¼ö°¡ ÀÖ´Ù. À̰ÍÀº »ç¶÷ó·³ °íµî»ý¹°Ã¼¿¡¼­ ³Ê¹«³ª ¸¹Àº Á¤º¸¸¦ ´ã°í ÀÖ¾î, ¾öû³­ ±æÀÌ(»ç¶÷¿¡ À־ Àü DNA¸¦ ±æÀ̷ΠµûÁö¸é ¾à 2m°¡ µÈ´Ù)°¡ µÈ DNA¸¦ ÀÛÀº ÇÙÀ̶õ °ø°£¼Ó¿¡ º¸°üÇϱâ À§Çؼ­ ¸¸µé¾îÁø ±¸Á¶ÀÌ´Ù. ÀÌ ¿°»öüÀÇ ¼ö´Â »ý¹°ÀÇ Á¾¿¡ µû¶ó ´Ù¸£¸ç »ç¶÷ÀÇ °æ¿ì´Â 46°³ÀÌ´Ù. 
¿µ¹® chromosome abnormality ÇÑ±Û ¿°»öüÀÌ»ó
¼³¸í   
  ¿°»öüÀÇ ¼ö³ª ±¸Á¶ÀÇ ÀÌ»ó. ÀÌ»óÀÌ »ý±ä ¼¼Æ÷³ª °³Ã¼´Â À¯ÀüÀûÀΠÀÌ»óÀ» ÀÏÀ¸ÄÑ »ç¶÷ÀÇ °æ¿ì, ´Ù¿î ÁõÈıº-ÅͳʠÁõÈıº µûÀ§ÀÇ ¿©·¯ °¡Áö ÇüÅ·Π³ªÅ¸³­´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fragile nail
    Ãë¾à¼Õ¹ßÅé
  • fragile site
    Ãë¾àºÎÀ§
  • fragile X syndrome
    ¿©¸°XÁõÈıº
  • accessory chromosome
    µ¡¿°»öü
  • acentric chromosome
    ¹«Áß½ÉÀý¿°»öü
  • autosomal chromosome
    º¸Åë¿°»öü, »ó¿°»öü
  • acrocentric chromosome
    ³¡°ç¸Åµì¿°»öü
  • bacterial artificial chromosome
    ¹ÚÅ׸®¾Æ¼ºÀΰø¿°»öü
  • bivalent chromosome
    À̰¡¿°»öü
  • circular chromosome
    °í¸®¿°»öü
  • chromosome
    ¿°»öü
  • chromosome association
    ¿°»öüÁ¢ÇÕ
  • chromosome band
    ¿°»öü¶ì
  • chromosome breakage
    ¿°»öü¼Õ»ó
  • chromosome bridge
    ¿°»öü´Ù¸®, ¿°»öü±³
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chromosome
    ¿°»öü
  • autosomal chromosome
    º¸Åë¿°»öü
  • Philadelphia chromosome
    Çʶóµ¨ÇǾƿ°»öü
  • sex chromosome
    ¼º¿°»öü
  • Y chromosome
    ³²¼º¿°»öü, ¿ÍÀÌ¿°»öü
  • chromosome translocation
    ¿°»öüÀüÀ§
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fragile nail
    Ãë¾à¼Õ¹ßÅé
  • fragile X syndrome
    À¯¾à¿¢½ºÁõÈıº
  • accessory chromosome
    (¢¡supernumerary chromosome) °úÀ׿°»öü
  • acentric chromosome
    ¹«Áß½ÉÀý¿°»öü
  • acrocentric chromosome
    ³¡°ç¸Åµì¿°»öü
  • autosomal chromosome
    º¸Åë¿°»öü
  • chromosome abnormality
    ¿°»öüÀÌ»ó
  • chromosome association
    ¿°»öüÁ¢ÇÕ
  • bivalent chromosome
    µÎ¹è¼ö¿°»öü
  • chromosome band
    ¿°»öü¶ì
  • chromosome breakage
    ¿°»öü¼Õ»ó
  • chromosome bridge
    ¿°»öü´Ù¸®, ¿°»öü±³
  • chromosome
    ¿°»öü
  • chromosome chain
    ¿°»öü»ç½½, ¿°»öü°í¸®
  • chromosome configuration
    ¿°»öüÁ¢ÇÕÇü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fragile
    Ãë¾à
  • fragile nail
    Ãë¾à¼Õ¹ßÅé
  • fragile osteosclerosis
    Ãë¾à °ñ°æÈ­
  • fragile x syndrome
    À¯¾à X ÁõÈıº
  • Philadelphia chromosome
    Çʶóµ¨ÇÇ¾Æ ¿°»öü
  • Philadelphia chromosome =Ph
    Çʶóµ¨ÇÇ¾Æ ¿°»öü
  • Philadelpia chromosome
    Çʶóµ¨ÇǾƿ°»öü
  • X chromosome
    X¿°»öü.
  • X chromosome
    X ¿°»öü
  • Y chromosome
    Y¿°»öü.
  • accessory chromosome
    À̼º¿°»öü(ì¶àõæøßäô÷).
  • acentric chromosome
    ¹«Áß½ÉÀý¿°»öü(Ùíñéãýï½æøßäô÷).
  • acrocentric chromosome
    ´ÜºÎÂø»çÇü ¿°»öü(Ó®Üõó·Þêúþæøßäô÷), ¼±´ÜºÎºÎÂø¿°»öü.
  • acrocentric chromosome
    ³¡°çÁß½ÉÀý¿°»öü
  • anuliform chromosome
    °í¸®¿°»öü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fragile
    Ãë¾à
  • fragile nail
    Ãë¾à¼Õ¹ßÅé
  • fragile osteosclerosis
    Ãë¾à °ñ°æÈ­
  • fragile x syndrome
    À¯¾à X ÁõÈıº
  • accessory chromosome
    À̼º¿°»öü(ì¶àõæøßäô÷).
  • acentric chromosome
    ¹«Áß½ÉÀý¿°»öü(Ùíñéãýï½æøßäô÷).
  • acrocentric chromosome
    ´ÜºÎÂø»çÇü ¿°»öü(Ó®Üõó·Þêúþæøßäô÷), ¼±´ÜºÎºÎÂø¿°»öü.
  • acrocentric chromosome
    ³¡°çÁß½ÉÀý¿°»öü
  • anuliform chromosome
    °í¸®¿°»öü
  • arm of chromosome
    ¿°»öüÆÈ
  • bacterial chromosome
    ¼¼±Õ¿°»öü
  • bivalent chromosome
    À̰¡¿°»öü(¡­æøßäô÷).
  • chromosome
    ¿°»öü(æøßäô÷).
  • chromosome
    ¿°»öü
  • chromosome
    ¿°»öüÀç°áÇÕ.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Anuliform chromosome
    °í¸®¿°»öü
    [¿¾ ¿ë¾î] À±»ó¿°»öü
  • Acrocentric chromosome
    ³¡°çÁß½ÉÀý¿°»öü
    [¿¾ ¿ë¾î] ÷µ¿¿øÃ¼¿°»öü
  • Quadrivalent chromosome
    ³×¹è¼ö¿°»öü
    [¿¾ ¿ë¾î] »ç°¡¿°»öü
  • Daughter chromosome
    µþ¿°»öü
    [¿¾ ¿ë¾î] ³¶¿°»öü
  • Mitochondrial chromosome
    »ç¸³Ã¼¿°»öü
    [¿¾ ¿ë¾î] »ç¸³Ã¼¿°»öü
  • Matrix of chromosome
    ¿°»öü¹ÙÅÁÁú
    [¿¾ ¿ë¾î] ¿°»öü±âÁú
  • Numeral aberration of chromosome
    ¿°»öü¼öÀÌ»ó
    [¿¾ ¿ë¾î] ¿°»öü¼öÀûÀÌ»ó
  • Arm of chromosome
    ¿°»öüÆÈ
    [¿¾ ¿ë¾î] ¿°»öü¿Ï
  • Morphological aberration of chromosome
    ¿°»öüÇüÅÂÀÌ»ó
    [¿¾ ¿ë¾î] ¿°»öüÇüÅÂÀÌ»ó
  • Satellite chromosome
    À§¼º¿°»öü
    [¿¾ ¿ë¾î] À§¼º¿°»öü
  • Submetacentric chromosome
    Áß¾Ó°çÁß½ÉÀý¿°»öü
    [¿¾ ¿ë¾î] ¾ÆÁß¾Óµ¿¿øÃ¼¿°»öü
  • Metacentric chromosome
    Áß¾ÓÁß½ÉÀý¿°»öü
    [¿¾ ¿ë¾î] Áß¾Óµ¿¿øÃ¼¿°»öü
  • Nucleolar chromosome
    ÇÙ¼Òü¿°»öü
    [¿¾ ¿ë¾î] ÇÙ¼Òü¿°»öü
  • Nucleolar chromosome
    ÇÙ¼Òü¿°»öü
    [¿¾ ¿ë¾î] ÇÙ¼Òü¿°»öü,ÇÙÀο°»öü
  • Univalent chromosome
    Ȭ¹è¼ö¿°»öü
    [¿¾ ¿ë¾î] ´Ü°¡¿°»öü
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fragile site
    Ãë¾àºÎÀ§(öªå°Ý»êÈ)
  • fragile X syndrome
    Ãë¾à(öªå°) X ÁõÈıº(ñøý¦ÏØ)
  • half-of-the-sites reactivity
    ¹Ý(Úâ)ÀÚ¸® ¹ÝÀÀ¼º (Úãëëàõ)
  • splice sites
    ½ºÇöóÀ̽º ÀÚ¸®
  • switching sites
    ¾ù¹Ù²ñ ÀÚ¸®
  • upstream activation sites
    À­ÂÊ È°¼ºÈ­(üÀàõûù)ÀÚ¸®
  • chromosome
    ¿°»öü(æøßäô÷)
  • chromosome break
    ¿°»öü(æøßäô÷) ºÎ·¯Áü
  • chromosome jumping
    ¿°»öü(æøßäô÷) ¶Ù±â
  • chromosome map
    ¿°»öü Áöµµ(æøßäô÷ò¢Óñ)
  • chromosome rearrangement
    ¿°»öü Àç¹è¿­(æøßäô÷î¢ÛÕæï)
  • chromosome scaffold
    ¿°»öü °ñ°Ý(æøßäô÷ÍéÌ«)
  • chromosome set
    ¿°»öü(æøßäô÷) Çѹú
  • chromosome substitution
    ¿°»öü ġȯ(æøßäô÷öÇüµ)
  • chromosome walking
    ¿°»öü(æøßäô÷) °È±â
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chromosome
    ¿°»öü
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
fra(X) fragile X chromosome, fragile X syndrome
FRAX fragile [chromosome] X
Xp paternal chromosome X; short arm of chromosome X
AFRAX autism-fragile X [syndrome]
FHIT fragile histidine triad [gene]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
FS Fragile Sites
AEBS Antiestrogen binding sites
DHS DNAse I hypersensitive sites
EBS ETS binding sites
HS Hypersensitive sites
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • fragile osteosclerosis
    Ãë¾à °ñ°æÈ­
  • fragile x syndrome
    ÇÁ·¡ÀÚÀÏ ¿§½º ÁõÈıº
    À¯ÀüÀÚ X ¿°»öüÀÇ Àå¿Ï
  • banding technique chromosome
    ´ë»ó ±â¼ú ¿°»öü
  • chromosome
    ¿°»öü
  • chromosome 4
    4¹ø ¿°»öü
  • chromosome aberration
    ¿°»öü ÀÌ»ó
    ¿°»öüÀÇ ¼ö ¹× ±¸Á¶»óÀÇ ÀÌ»ó. ÀÌ»óÀÌ »ý±ä ¼¼Æ÷ ¶Ç´Â °³Ã¼´Â À¯ÀüÀûÀÎ ÀÌ»óÀ» ÀÏÀ¸Å°¹Ç·Î ¿°»öü µ¹¿¬º¯À̶ó°íµµ ÇÑ´Ù. ÀÚ¿¬ÀûÀ¸·Î ¶Ç´Â È­ÇÐÀû, ¹°¸®ÀûÀÎ Àڱؿ¡ ÀÇÇÏ¿© ÀÎÀ§ÀûÀ¸·Îµµ ÀϾ¸ç ¾çÀÚ »çÀÌ¿¡´Â ¾çÀûÀÎ Â÷ÀÌ´Â À־ ÁúÀûÀÎ Â÷ÀÌ´Â ¾ø´Ù. º¯ÀÌÀÇ ¾ç»óÀº ¼¼Æ÷ºÐ¿­ ¶§ ¶Ç´Â ħ»ù ¿°»öü µî¿¡¼­ °üÂûµÈ´Ù.¡¼¿°»öü ¼öÀÇ ÀÌ»ó¡½ Á¤»ó ü¼¼Æ÷´Â ¹Ý¼ö¿°»öü¸¦ °¡Áø Á¤ÀÚ¿Í ³­ÀÚÀÇ ÇÕü¿¡ ÀÇÇÏ¿© 2¹èü
  • chromosome abnormality
    ¿°»öü ÀÌ»ó
  • chromosome association
    ¿°»öü Á¢ÇÕ
  • chromosome bridge
    ¿°»öü ±³
  • chromosome configuration
    ¿°»öü Á¢ÇÕÇü
  • chromosome longarm deletion syndrome
    ¿°»öü ÀåÁö °á¼Õ ÁõÈıº
  • chromosome mapping
    ¿°»öü Áöµµ ÀÛ¼º
    ƯÁ¤ÀÇ ¿°»öü »ó¿¡ Àִ ƯÁ¤ÀÇ À¯ÀüÀÚ ºÎÀ§¸¦ °áÁ¤Çϰí, À¯ÀüÀÚÀÇ »ó´ëÀû À§Ä¡¸¦ ³ªÅ¸³»´Â ¿°»öü Áöµµ¸¦ ÀÛ¼ºÇÏ´Â °úÁ¤À» ¸»ÇÑ´Ù. ±â¹ýÀ¸·Î¼­´Â Åë°èÀû ºÐ¼®À» ÀÌ¿ëÇÏ´Â °¡°è ¿¬±¸, ü¼¼Æ÷ ±³Àâ, ¿°»öü °á½Ç ÁöµµÀÇ ÀÛ¼º µîÀ» Æ÷ÇÔÇÑ´Ù.
  • chromosome monad
    ÀϺР¿°»öü
  • chromosome painting
    ¿°»öü ÆäÀÎÆÃ, ¿°»öü Âø»ö
  • chromosome recombination
    ¿°»öü Àç°áÇÕ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
chromosome fragile sites Heritable sensitive regions of chromosomes which show up in vitro as non-staining bands. They are associated with chromosome breakage and other aberrations, and, when located on sex chromosomes, they produce phenotypic abnormalities. No abnormal phenotype has been definitely identified with autosomal fragile sites, but some rare autosomal recessive disorders may be due to homozygosity for fragile sites. Fragile sites are designated by the letters "fra" followed by the designation for the specific chromosome and locus.
(12 Dec 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
fragile x chromosome X chromosome with a fragile site associated with a frequent form of mental retardation. The fragile X chromosome was first sighted by Herbert A. Lubs in 1969. The fragile X is also called FRAXA (the second A signifies it was the first FRAgile site found on the X chromosome). It is due a trinucleotide repeat (a recurring motif of 3 bases) in the DNA at that spot.
(12 Dec 1998)
syndrome, fragile x The most common heritable form of mental retardation. Fragile x syndrome is due to mutation (changes) at the fragile x site and so perforce is x-linked (carried on the x chromosome). Although it is usually more severe in males than females, the syndrome is due to a dynamic mutation (a trinucleotide repeat) that can change in length and hence in severity from generation to generation, from person to person, and even within a given person. The fragile x syndrome is also known as the martin-bell syndrome in honor of their discovery of it in 1943.
(12 Dec 1998)
fragile site Places on chromosomes that tend to break more often than other places. These places also tend to be where chromosomal translocations (a type of chromosomal mutation) occur.
(09 Oct 1997)
fragile X syndrome <syndrome> most frequent cause of mental retardation. There is an expanded trinucleotide repeat CGG in the fra(X) gene. There is usually a constricted section on the long arm of the X chromosome.
After puberty these patients often exhibit large prominent ears, long narrow face, coarse facial features and macroorchidism. Mental retardation in males is characteristic although the manifestations of the syndrome are highly variable.
A preponderance of males are affected but it also affects 30% of carrier females and about 20% of obligate carrier males are not affected. The complexity in the inheritance pattern comes from the fact that these obligate carrier males (transmitting males) pass on the mutation to all their daughters (unaffected). most of the sons of carrier females with the mutation are mentally retarded but of their daughters, only 1/3 are retarded while 1/3 are borderline retarded and 1/3 are normal.
Penetrance of the disease is variable within families and among siblings. Another unique characteristic of this syndrome, which is referred to as the Sherman Paradox is the fact that the risk of a family member being abnormal when gene-positive depends on the position of the proband in the pedigree.
Sons of phenotypically normal but transmitting males have no risk of being mentally affected, but grandsons and great-grandsons of the transmitting a male have a much higher risk of mental retardation (40% and 50%, respectively). On the other hand, if the carrier female expresses the mental handicap her sons have a 50% risk of mental retardation.
The classical method of confirming diagnosis is culture of lymphocytes in a folate-free medium (or supplemented with trimethoprim, methotrexate or FUdR) and microscopic detection of the fragile site (Xq27.3). Expression is seen in less than 50% of the cells of affected individuals but the test is not applicable to carrier detection as there is a high false negative rate (60%).
The fragile-X gene (FMR-1), which contains tandemly repeated trinucleotide sequences (CGG repeats) on its 5' end, can be detected with PCR or Southern blot techniques. Normal controls show 6-50 CGG repeats, whereas mutation in affected males or heterozygous females can contain as many as 1,000 CGG repeat units.
The test is indicated for individuals with compatible mental retardation, developmental delays or autism, or for those that have a family history of the syndrome. It is also indicated for prenatal detection in offspring of carrier females.
Inheritance: sex-linked.
Incidence: 1 in 1200 males and 1 in 2500 females.
(17 Dec 1997)
attachment sites <microbiology, molecular biology> Particular loci in both bacterial and phage DNA molecules at which phage DNA is integrated into the bacterial DNA by recombination between these sites.
(12 Dec 1998)
binding sites The reactive parts of a macromolecule that directly participate in its specific combination with another molecule.
(12 Dec 1998)
binding sites, antibody Local surface sites on antibodies which react with antigen determinant sites on antigens. They are formed from parts of the variable regions of the fab fragment of the immunoglobulin.
(12 Dec 1998)
contact sites A Developmentally regulated adhesion sites that appear on the ends of aggregation competent Dictyostelium discoideum at the stage when the starved cells begin to come together to form the grex. Originally detected by the use of Fab fragments of polyclonal antibodies, raised against aggregation competent cells and adsorbed against vegetative cells, to block adhesion in EDTA containing medium. (Cell cell adhesion mediated by contact sites A, unlike that mediated by contact sites B, is not divalent cation sensitive). The fact that a mutant deficient in csA behaves perfectly normally in culture is puzzling.
(18 Nov 1997)
contact sites B Developmentally regulated adhesion sites that appear on the ends of aggregation competent Dictyostelium discoideum at the stage when the starved cells begin to come together to form the grex. Originally detected by the use of Fab fragments of polyclonal antibodies, raised against aggregation competent cells and adsorbed against vegetative cells, to block adhesion in EDTA containing medium. (Cell cell adhesion mediated by contact sites A, unlike that mediated by contact sites B, is not divalent cation sensitive). The fact that a mutant deficient in csA behaves perfectly normally in culture is puzzling.
(18 Nov 1997)
crohn disease: sites <radiology> Oesophagus: rare, stomach (2-20%): granulomatous gastritis, pseudo-post Bilroth-I appearance, ramshorn sign, antral-duodenal fistula, duodenum (4-10%): almost always associated with gastric involvement, bulb and proximal half of duodenum, small bowel (80%): regional enteritis, terminal ileum (alone/in combination): 95%, jejunum/ileum: 15%, commonly associated with medial caecal defect, colon (22-55%): granulomatous colitis, particularly on the right side, transverse stripe sign: contrast within coarse mucosal folds, rectum (35-50%) see: Crohn disease
(12 Dec 1998)
sequence tagged sites Short, tagged tracts of DNA sequence that are used as landmarks in genome mapping. In most instances, 200 to 500 base pairs of sequence define a sequence tagged site (sts) that is operationally unique in the human genome (i.e., can be specifically detected by the polymerase chain reaction in the presence of all other genomic sequences). The overwhelming advantage of stss over mapping landmarks defined in other ways is that the means of testing for the presence of a particular sts can be completely described as information in a database.
(12 Dec 1998)
sequence-tagged sites Short stretches of DNA sequences that can be detected by use of the polymerase chain reaction.
(05 Mar 2000)
immunologically privileged sites Sites where allografts are not readily rejected, probably because these particular areas have poor lymphatic drainage.
(05 Mar 2000)
accessory chromosome A chromosome existing without its normal homologous chromosome; at the reduction division of gametogenesis an accessory chromosome is likely to be included in one daughter cell and not in the other, but may be lost completely by lagging behind on the equatorial plate.
Synonym: monosome, odd chromosome, unpaired allosome, unpaired chromosome.
(05 Mar 2000)
acentric chromosome A fragment of a chromosome lacking a centromere and unable to attach to the mitotic spindle, therefore unable to take part in the division of a nucleus and randomly distributed in daughter cells.
Synonym: acentric fragment.
(05 Mar 2000)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Chromosome Fragile Sites - »õâ Specific loci that show up during KARYOTYPING as a gap (an uncondensed stretch in closer views) on a CHROMATID arm after culturing cells under specific conditions. These sites are associated with an increase in CHROMOSOME FRAGILITY. They are classified as common or rare, and by the specific culture conditions under which they develop. Fragile site loci are named by the letters "FRA" followed by a designation for the specific chromosome, and a letter which refers to which fragile site of that chromosome (e.g. FRAXA refers to fragile site A on the X chromosome. It is a rare, folic acid-sensitive fragile site associated with FRAGILE X SYNDROME.)
    Synonyms : Chromosome Fragile Site, Fragile Site, Chromosome, Site, Chromosome Fragile, Sites, Chromosome Fragile
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fragile
    ±úÁö±â ½¬¿î; Çã¾àÇÑ
  • fragile
    ºÎ¼­Áö±â ½¬¿î;¸öÀÌ ¾àÇÑ. fragilely ad.
  • A chromosome
    A¿°»öü(°úÀ× ¿°»öü ÀÌ¿ÜÀÇ º¸Åë ¿°»öü)
  • Philadephia chromosome
    Çʶóµ¨ÇÇ¾Æ ¿°»öü
  • X chromosome
    X¿°»öü
  • Y chromosome
    Y¿°»öü
  • chromosome
    ¿°»öü
  • chromosome number
    ¿°»öü¼ö 
  • chromosome translocation
    ¿°»öü ÀüÁÂ
  • criminal chromosome
    ¹üÁËÀÚ ¿°»öü(³²¼ºÀÇ ±ØÈ÷ ÀϺο¡ º¸ÀÌ´Â ¿©ºÐÀÇ Y¿°»öü)
  • sex chromosome
    ¼º¿°»öü
  • x-chromosome
    ¿°»öü
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á